Create Account Sign In
Maximum: 1 CME cr.
1 new discussion post (10 published)
Sign in to view your progression
Programme overview Progr...
Learning objectives Learn...
Target audience Targe...
The credit designation The...
Disclosure Discl...

This educational module focusses on primary and metastatic mucinous tumours and new approaches in the clinical management. In the first part the pathologist’s view will be discussed, focussing on the two distinct patterns of growth, the expansile and infiltrating types. Moreover, the gross and pathologic criteria for distinguishing between a primary ovarian mucinous carcinoma and a mucinous carcinoma metastatic to the ovary will be evaluated.

The impact of the 2014 WHO classification on surgical approach to manage mucinous ovarian cancer and the place of fertility-sparing surgery as well as peritoneal and lymph node staging according to the expansile and infiltrating types will be considered.

Finally, there will be an update on medical management and controversies surrounding the molecular landscape.

The learning objectives are as follows:

1. To master the knowledge about the particularities of pathology in mucinous tumors

2. To learn about the surgical approach in mucinous tumors

3. To acquire information about medical treatment and update on recent molecular studies. 

The ideal profile of the course candidate is gynaecological oncologists with special interest in the mucinous tumours treatment, aiming to refine their skills, candidates should be fluent in the English language.

The ESGO Mucinous tumours e-module, organized by European Society of Gynaecological Oncology (ESGO), is accredited by the EACCME®, the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
Each medical specialist should claim only those credits that he/she actually spent in the educational activity.
The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.
Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits(TM).
Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

 

All speakers have reported no potential conflict of interests.

Restrictions in the histopathological diagnosis of mucinous ovarian carcinoma
New insights into surgical management of mucinous ovarian cancer
Medical treatment and update on recent molecular studies
Assessment & Certificate

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies